Aurinia Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. 

CEO
Peter S. Greenleaf
CEOPeter S. Greenleaf
Employees
300
Employees300
Headquarters
Edmonton, Alberta
HeadquartersEdmonton, Alberta
Founded
1993
Founded1993
Employees
300
Employees300

AUPH Key Statistics

Market cap
729.40M
Market cap729.40M
Price-Earnings ratio
-11.69
Price-Earnings ratio-11.69
Dividend yield
Dividend yield
Average volume
1.47M
Average volume1.47M
High today
$5.55
High today$5.55
Low today
$5.09
Low today$5.09
Open price
$5.40
Open price$5.40
Volume
1.70M
Volume1.70M
52 Week high
$12.43
52 Week high$12.43
52 Week low
$4.71
52 Week low$4.71

AUPH News

Yahoo Finance 12h
Aurinia Pharmaceuticals Inc. Q1 2024 Earnings Call Transcript - Yahoo Finance

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript May 2, 2024 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS...

Aurinia Pharmaceuticals Inc. Q1 2024 Earnings Call Transcript - Yahoo Finance
TipRanks 2d
Aurinia Pharmaceuticals Sees Robust Growth in 2024 - TipRanks.com - TipRanks

Aurinia Pharmaceuticals (AUPH) has released an update. Aurinia Pharmaceuticals has reported significant growth with a 46% increase in net revenue, reaching $50...

TipRanks 3d
Aurinia Advances Lupus Nephritis Education and Advocacy - TipRanks.com - TipRanks

Aurinia Pharmaceuticals (AUPH) has released an update. Aurinia Pharmaceuticals Inc. is enhancing lupus nephritis awareness and education during Lupus Awareness...

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

More AUPH News

TipRanks 4d
Aurinia Pharmaceuticals: FDA approves updated LUPKYNIS label

Aurinia Pharmaceuticals announced that the FDA has approved a label update for LUPKYNIS. The updated label no longer includes language indicating that the safet...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.